[1]Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001 ; 48 (4) : 526-535.
[2]Beaugerie L., Svrcek M., Seksik P. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166-175. 1
[3]Winther K.V., Jess T., Langholz E. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004;2:1088-1095. 12
[4]Popivanova B.K., Kitamura K., Wu Y. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest. 2008;118:560-570. 2
[5]Wang YR, Cangemi JR, Loftus EV, Picco MF. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol 2013 ; 108 (3) : 444-449.
[6]Liu X, Goldblum JR, Zhao Z, et al. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma : in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma. Am J Surg Pathol 2012 ; 36 (8) : 1228-1233.
[7]Viennois E., Chen F., Merlin D. NF-κB pathway in colitis-associated cancers. Transl Gastrointest Cancer. 2013;2:21-29. 1
[8]Danese S, Malesci A, Vetrano S. Colitis-associated cancer: the dark side of inflammatory bowel disease. Gut 2011 ; 60 (12) : 1609-10.
[9]Tarmin L., Yin J., Harpaz N. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 1995;55:2035-2038. 10
[10]Rapozo D.C.M., Grinmann A.B., Carvalho A.T.P. Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease. Int J Colorectal Dis. 2009;24:1141-1148. 10
[11]Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000 ; 60 (13) : 3333-3337.
[12]Svrcek M, El-Bchiri J, Chalastanis A et al. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. J Clin Oncol 2007 ; 25 (27) : 4231-4238.
[13]Connelly T.M., Berg A.S., Harris L.R. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms. Surgery. 2014;156:253-262. 2
[14]Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9(10):599-608.
[15]Gagnière J., Raisch J., Veziant J. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22:501-518. 2
[16]Richard M.L., Liguori G., Lamas B. Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes. 2018;9:131-142. 2
[17]Jacouton E., Chain F., Sokol H. Probiotic Strain Lactobacillus casei BL23 prevents colitis-associated colorectal cancer. Front Immunol. 2017;8:1553.